Amgis Lifescience Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 04-01-2025
- Paid Up Capital ₹ 4.50 Cr
as on 04-01-2025
- Company Age 53 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 63.29 Cr
as on 04-01-2025
- Satisfied Charges ₹ 47.88 Cr
as on 04-01-2025
About Amgis Lifescience
The Corporate was formerly known as Amardeep Chemicals Industries Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.50 Cr.
The company currently has active open charges totaling ₹63.29 Cr. The company has closed loans amounting to ₹47.88 Cr, as per Ministry of Corporate Affairs (MCA) records.
Dharmendrabhai Patel, Shantaben Patel, and Yash Patel serve as directors at the Company.
- CIN/LLPIN
U99999GJ1971PLC109282
- Company No.
109282
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Sep 1971
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Valsad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Amgis Lifescience?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharmendrabhai Patel  | Director | 19-Aug-2016 | Current |
| Shantaben Patel | Director | 19-Aug-2016 | Current |
| Yash Patel | Director | 06-Dec-2021 | Current |
Financial Performance of Amgis Lifescience.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Amgis Lifescience?
Unlock access to Amgis Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sigma Scientific Glass Private LimitedActive 19 years 10 monthsDharmendrabhai Patel is a mutual person
Sigma Roto Lining LlpActive 8 years 17 daysDharmendrabhai Patel and Shantaben Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 13 Dec 2023 | ₹17.50 Cr | Open |
Hdfc Bank Limited Creation Date: 07 May 2022 | ₹1.62 Cr | Open |
Hdfc Bank Limited Creation Date: 31 Dec 2021 | ₹44.17 Cr | Open |
How Many Employees Work at Amgis Lifescience?
Unlock and access historical data on people associated with Amgis Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amgis Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amgis Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
